AXTI vs. ARWR

Last updated Aug 1, 2026

AXTI (AXT, Inc.) and ARWR (Arrowhead Pharmaceuticals, Inc.) are both stocks. AXTI operates in Semiconductor Equipment & Materials (Technology), while ARWR operates in Biotechnology (Healthcare). Over the past 10 years, AXTI returned 32.40%/yr vs 30.88%/yr for ARWR. Their 0.14 correlation means their historical movements had little consistent relationship.

Performance

AXTI vs. ARWR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AXT, Inc. (AXTI) and Arrowhead Pharmaceuticals, Inc. (ARWR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, AXTI achieves a 269.60% return, which is significantly higher than ARWR's 27.50% return. Both investments have delivered pretty close results over the past 10 years, with AXTI having a 32.40% annualized return and ARWR not far behind at 30.88%.

AXTI

• 1D: 28.74%
• 1M: 6.73%
• 6M: 225.94%
• YTD: 269.60%
• 1Y: 3,047.40%
• 3Y*: 169.71%
• 5Y*: 42.74%
• 10Y*: 32.40%
• ALL TIME*: 6.40%

ARWR

• 1D: -3.06%
• 1M: 0.79%
• 6M: 22.10%
• YTD: 27.50%
• 1Y: 431.39%
• 3Y*: 35.96%
• 5Y*: 4.09%
• 10Y*: 30.88%
• ALL TIME*: -0.69%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
ARWR Arrowhead Pharmaceuticals, Inc.	$205.45M	$188.79M	$175.31M
AXTI AXT, Inc.	$521.22M	$514.43M	$822.68M

AXTI vs. ARWR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
AXTI AXT, Inc.	269.60%	653.46%	-9.58%	-45.21%	-50.28%	-7.94%	120.00%	-0.00%	-50.00%	81.25%
ARWR Arrowhead Pharmaceuticals, Inc.	27.50%	253.14%	-38.56%	-24.56%	-38.82%	-13.59%	20.97%	410.71%	237.50%	137.42%

Correlation

The correlation between AXTI and ARWR is 0.10, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.10
Correlation (3Y) Balances recent behavior with more history.	0.22
Correlation (5Y) Shows whether the relationship held over a longer period.	0.27
Correlation (10Y) Provides a long-term view across more market conditions.	0.26
Correlation (All Time) Calculated using the full available price history since May 21, 1998	0.14

The correlation between AXTI and ARWR shifts across timeframes, from 0.10 (1 year) to 0.27 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap AXTI : $3.07B ARWR : $11.92B
EPS AXTI : $0.08 ARWR : -$2.16
PS Ratio AXTI : 24.26 ARWR : 19.00
PB Ratio AXTI : 4.08 ARWR : 20.13
Total Revenue (TTM) AXTI : $125.51M ARWR : $622.01M
Gross Profit (TTM) AXTI : $40.39M ARWR : $529.27M
EBITDA (TTM) AXTI : $17.91M ARWR : -$168.38M

Return for Risk

AXTI vs. ARWR — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

AXTI

AXTI Risk / Return Rank: 99
AXTI Sharpe Ratio Rank: 100
AXTI Sortino Ratio Rank: 99
AXTI Omega Ratio Rank: 98
AXTI Calmar Ratio Rank: 100
AXTI Martin Ratio Rank: 100

ARWR

ARWR Risk / Return Rank: 99
ARWR Sharpe Ratio Rank: 100
ARWR Sortino Ratio Rank: 99
ARWR Omega Ratio Rank: 98
ARWR Calmar Ratio Rank: 100
ARWR Martin Ratio Rank: 100

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

AXTI vs. ARWR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for AXT, Inc. (AXTI) and Arrowhead Pharmaceuticals, Inc. (ARWR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	AXTI	ARWR	Difference
Sharpe ratio: Return per unit of total volatility	19.01	6.69	+12.32
Sortino ratio: Return per unit of downside risk	5.30	5.72	-0.43
Omega ratio: Gain probability vs. loss probability	1.64	1.70	-0.06
Calmar ratio: Return relative to maximum drawdown	38.57	17.83	+20.74
Martin ratio: Return relative to average drawdown	117.62	51.66	+65.96

AXTI vs. ARWR - Sharpe Ratio Comparison

The current AXTI Sharpe Ratio is 19.01, which is higher than the ARWR Sharpe Ratio of 6.69. The chart below compares the historical Sharpe Ratios of AXTI and ARWR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

AXTI vs. ARWR - Drawdown Comparison

The maximum AXTI drawdown since its inception was -98.57%, roughly equal to the maximum ARWR drawdown of -99.24%. Use the drawdown chart below to compare losses from any high point for AXTI and ARWR.

Drawdown Indicators

	AXTI	ARWR	Difference
Max Drawdown Largest peak-to-trough decline	-98.57%	-99.24%	+0.67%
Max Drawdown (1Y) Largest decline over 1 year	-73.75%	-24.64%	-49.11%
Max Drawdown (3Y) Largest decline over 3 years	-78.52%	-74.70%	-3.82%
Max Drawdown (5Y) Largest decline over 5 years	-88.79%	-87.89%	-0.90%
Max Drawdown (10Y) Largest decline over 10 years	-92.45%	-88.96%	-3.49%
Current Drawdown Current decline from peak	-57.09%	-47.91%	-9.18%
Average Drawdown Average peak-to-trough decline	-82.15%	-81.07%	-1.08%
Ulcer Index Depth and duration of drawdowns from previous peaks	24.14%	8.49%	+15.65%

Volatility

AXTI vs. ARWR - Volatility Comparison

AXT, Inc. (AXTI) has a higher volatility of 57.24% compared to Arrowhead Pharmaceuticals, Inc. (ARWR) at 23.10%. This indicates that AXTI's price experiences larger fluctuations and is considered to be riskier than ARWR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	AXTI	ARWR	Difference
Volatility (1M) Calculated over the trailing 1-month period	57.24%	23.10%	+34.14%
Volatility (6M) Calculated over the trailing 6-month period	122.91%	39.03%	+83.88%
Volatility (1Y) Calculated over the trailing 1-year period	149.65%	65.63%	+84.02%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	100.30%	64.63%	+35.67%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	85.23%	74.38%	+10.85%

Dividends

AXTI vs. ARWR - Dividend Comparison

Neither AXTI nor ARWR has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both AXTI and ARWR in my portfolio?

AXTI and ARWR have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, AXTI or ARWR?

AXTI has higher volatility (57.24%) compared to ARWR (23.10%). In terms of maximum drawdown, AXTI dropped -98.57% vs ARWR's -99.24%.

Which has better risk-adjusted returns?

AXTI currently has the higher Sharpe Ratio (19.01 vs 6.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.